Venous thromboembolism is a significant cause of morbidity and mortality worldwide. Anticoagulation is the preferred treatment, but is not feasible in some patients. Caval interruption is the treatment of choice for prevention of recurrent pulmonary embolism. This article looks at the development of caval interruption.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.12968/hmed.2008.69.9.31048 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!